What is NelDerm?
NelDerm operates at the intersection of biomedical engineering and clinical care, focusing on the development of specialized pressure offloading devices. Its core product, the HeelP.O.D., integrates advanced memory foam technology with fluid-resistant materials to ensure both patient comfort and hygienic compliance. By facilitating continuous heel access and visualization, the device allows healthcare professionals to maintain rigorous standards of care without compromising patient safety. The company's market position is defined by its commitment to reducing the incidence of pressure injuries, a persistent and costly issue in modern healthcare facilities. Through its focus on ergonomic design and ease of application, NelDerm effectively bridges the gap between complex medical requirements and practical, bedside utility.
How much funding has NelDerm raised?
NelDerm has raised a total of $750K across 1 funding round:
Other Financing Round
$750K
Other Financing Round (2022): $750K with participation from MedTech Projects, Bounce, and Magnet
Key Investors in NelDerm
MedTech Projects
A specialized consultancy firm focused on the innovation, safety, and regulatory certification of biomedical technologies for global healthcare markets.
Bounce
A nonprofit innovation hub providing essential resources, mentorship, and collaborative workspaces to support the scaling of high-growth startups.
Magnet
An organization dedicated to driving economic growth by providing hands-on support for product design and operational excellence in the manufacturing sector.
What's next for NelDerm?
With this major enterprise-level funding, NelDerm is poised to transition from a specialized product developer to a broader player in the clinical support market. The strategic roadmap likely involves scaling manufacturing capabilities to meet increasing demand from critical care units and investing in further clinical validation studies to solidify its market presence. By leveraging the expertise of its strategic partners, the company is expected to refine its supply chain and expand its distribution network, ensuring that its innovative offloading solutions become a standard component of pressure injury prevention protocols. As the company matures, the focus will shift toward long-term sustainability and the potential for diversifying its product portfolio to address additional patient care challenges.
See full NelDerm company page
